Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 31;16(2):215.
doi: 10.3390/v16020215.

The Potential of Usnic-Acid-Based Thiazolo-Thiophenes as Inhibitors of the Main Protease of SARS-CoV-2 Viruses

Affiliations

The Potential of Usnic-Acid-Based Thiazolo-Thiophenes as Inhibitors of the Main Protease of SARS-CoV-2 Viruses

Olga I Yarovaya et al. Viruses. .

Abstract

Although the COVID-19 pandemic caused by SARS-CoV-2 viruses is officially over, the search for new effective agents with activity against a wide range of coronaviruses is still an important task for medical chemists and virologists. We synthesized a series of thiazolo-thiophenes based on (+)- and (-)-usnic acid and studied their ability to inhibit the main protease of SARS-CoV-2. Substances containing unsubstituted thiophene groups or methyl- or bromo-substituted thiophene moieties showed moderate activity. Derivatives containing nitro substituents in the thiophene heterocycle-just as pure (+)- and (-)-usnic acids-showed no anti-3CLpro activity. Kinetic parameters of the most active compound, (+)-3e, were investigated, and molecular modeling of the possible interaction of the new thiazolo-thiophenes with the active site of the main protease was carried out. We evaluated the binding energies of the ligand and protein in a ligand-protein complex. Active compound (+)-3e was found to bind with minimum free energy; the binding of inactive compound (+)-3g is characterized by higher values of minimum free energy; the positioning of pure (+)-usnic acid proved to be unstable and is accompanied by the formation of intermolecular contacts with many amino acids of the catalytic binding site. Thus, the molecular dynamics results were consistent with the experimental data. In an in vitro antiviral assay against six strains (Wuhan, Delta, and four Omicron sublineages) of SARS-CoV-2, (+)-3e demonstrated pronounced antiviral activity against all the strains.

Keywords: 3CLpro; SARS-CoV-2; main protease; molecular modeling; usnic acid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Structure of (+)-and (−)-usnic acid and their natural sources. The images are taken from [46] with permission.
Scheme 1
Scheme 1
Synthesis of compounds 3a–g.
Figure 2
Figure 2
The curves of residual protease activity versus inhibitory concentration of compound (+)-3e.
Figure 3
Figure 3
The dependence of the initial rate of substrate cleavage by SARS-CoV-2 3CLpro without (A) or with a potential inhibitor (+)-3e (B). Each data point are an average of at least three independent experiments; the values are presented as the mean ± SE.
Figure 4
Figure 4
Contacts between atoms of the ligand and surrounding amino acid residues, as recorded throughout the entire simulation of the 3CLpro(+)-3e complex. The amino acids of the catalytic dyad are highlighted with a red square.
Figure 5
Figure 5
Contacts between atoms of the ligand and surrounding amino acid residues, as recorded throughout the entire simulation of the 3CLpro(+)-3g complex. The amino acids of the catalytic dyad are highlighted with a red square.
Figure 6
Figure 6
A summary of contacts recorded during molecular dynamics simulations. For complexes 3CLpro(+)-3e and 3CLpro(+)-3g, contacts are shown that were detectable for more than 20% of the simulation time for the 3CLpro(+)-1 complex, they were present for more than 10% of the simulation time. Various substituents are highlighted in red.
Figure 7
Figure 7
Molecular modelling study: Positioning of the studied ligands (+)-3e (A), (+)-3g (B) and (+)-UA (C), respectively, in the active binding site of subunit 3CLpro of the main protease. Letter designations S1–S3 correspond to significant cavities in the catalytic binding site.

Similar articles

Cited by

References

    1. Wise J. COVID-19: WHO Declares End of Global Health Emergency. BMJ. 2023;368:1041. doi: 10.1136/bmj.p1041. - DOI - PubMed
    1. Sahoo B.M., Ravi Kumar B.V.V., Sruti J., Mahapatra M.K., Banik B.K., Borah P. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. Front. Mol. Biosci. 2021;8:628144. doi: 10.3389/fmolb.2021.628144. - DOI - PMC - PubMed
    1. Jadhav P., Huang B., Osipiuk J., Zhang X., Tan H., Tesar C., Endres M., Jedrzejczak R., Tan B., Deng X., et al. Structure-Based Design of SARS-CoV-2 Papain-like Protease Inhibitors. Eur. J. Med. Chem. 2024;264:116011. doi: 10.1016/j.ejmech.2023.116011. - DOI - PMC - PubMed
    1. Jiang Y., Yin W., Xu H.E. RNA-Dependent RNA Polymerase: Structure, Mechanism, and Drug Discovery for COVID-19. Biochem. Biophys. Res. Commun. 2021;538:47–53. doi: 10.1016/j.bbrc.2020.08.116. - DOI - PMC - PubMed
    1. Lung J., Lin Y., Yang Y., Chou Y., Shu L., Cheng Y., Liu H.T., Wu C. The Potential Chemical Structure of Anti-SARS-CoV-2 RNA-dependent RNA Polymerase. J. Med. Virol. 2020;92:693–697. doi: 10.1002/jmv.25761. - DOI - PMC - PubMed